VYNE Therapeutics
VYNE
VYNE
41 hedge funds and large institutions have $1.1M invested in VYNE Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 15
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$43.3K | |
| 2 | +$6.63K | |
| 3 | +$2.83K | |
| 4 |
SG
StoneX Group
New York
|
+$2.08K |
| 5 |
TFA
Tobias Financial Advisors
Plantation,
Florida
|
+$1.65K |
Top Sellers
| 1 | -$165K | |
| 2 | -$14K | |
| 3 | -$9.32K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.9K |
| 5 |
Jane Street
New York
|
-$4.83K |